Phase I safety and pharmacokinetic (PK) study of SU014813 (S) in combination with docetaxel (D) in patients (pts) with solid tumors (STs)

被引：0
|
作者：
Schoffski, P.
机构：
[1] Univ Ziekenhuizen Leuven, Louvain, Belgium
[2] Erasmus MC, Rotterdam, Netherlands
[3] Pfizer SRL, Milan, Italy
[4] Pfizer Global Res & Dev, La Jolla, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.3554
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3554
引用
收藏
页数：1
相关论文
共 50 条
  • [41] A PHASE I DOSE-FINDING STUDY OF SUNITINIB (SU) IN COMBINATION WITH GEMCITABINE (G) IN PATIENTS (PTS) WITH ADVANCED SOLID TUMORS
    Michaelson, M. D.
    Schwarzberg, A.
    Ryan, D.
    McDermott, D.
    Shapiro, G. I.
    Tye, L.
    Chen, I.
    Selaru, P.
    Wang, E.
    Zhu, A.
    ANNALS OF ONCOLOGY, 2008, 19 : 156 - 156
  • [42] Phase I, pharmacokinetic (PK), pharmacodynamic (PD) study of lapatinib (L) in combination with sorafenib (S) in patients with advanced refractory solid tumors.
    Simonelli, M.
    Zucali, P. A.
    De Sanctis, R.
    Lorenzi, E.
    De Vincenzo, F.
    Rimassa, L.
    Tronconi, M. C.
    Personeni, N.
    Masci, G.
    Zuradelli, M.
    Perrino, M.
    Bertossi, M.
    Giordano, L.
    Santoro, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [43] Phase I study to assess pharmacokinetics (PK), QT/QTc effect, and safety of amrubicin in patients (pts) with advanced solid tumors
    Chen, N.
    Chawla, S. P.
    Chiorean, E. G.
    Read, W. L.
    Gorbaty, M.
    Mita, A. C.
    Yung, L.
    McNally, R.
    Renschler, M. F.
    Sharma, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [44] Phase I and pharmacokinetic (PK) study of weekly KOS-862 (Epothilone D) combined with gemcitabine (GEM) in patients (Pts) with advanced solid tumors.
    Marshall, JL
    Ramalingam, S
    Hwang, JJ
    Ramanathan, R
    Malik, S
    Egorin, M
    Hannah, A
    Cropp, GF
    Johnson, RG
    Belani, C
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 145S - 145S
  • [45] Phase I pharmacokinetic and sequence finding study of the combination of docetaxel and methotrexate in patients with solid tumours
    Louwerens, M
    Smorenburg, C
    Sparreboom, A
    Loos, WJ
    Verweij, J
    de Wit, R
    EUROPEAN JOURNAL OF CANCER, 2002, 38 (04) : 497 - 504
  • [46] A phase I clinical and pharmacokinetic study of paclitaxel and docetaxel given in combination in patients with solid tumours
    Angel Izquierdo, Miguel
    Garcia, Margarita
    Luis Ponton, Jose
    Martinez, Marisa
    Valenti, Vicente
    Navarro, Matilde
    Gil, Miguel
    Cardenal, Felipe
    Mesia, Ricard
    Perez, Xavier
    Salazar, Ramon
    Ramon Germa-Lluch, Josep
    EUROPEAN JOURNAL OF CANCER, 2006, 42 (12) : 1789 - 1796
  • [47] A phase I clinical and pharmacokinetic study of ipifarnib in combination with docetaxel in patients with advanced solid malignancies
    Awada, Ahmad
    Zhang, Steven
    Gil, Thierry
    de Valeriola, Dominique
    Lalami, Yassine
    De Porre, Peter
    Piccart-Gebhart, Martine J.
    CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 (05) : 991 - 1003
  • [48] SUNITINIB IN COMBINATION WITH CARBOPLATIN (C) PLUS PACLITAXEL (P) IN PATIENTS (PTS) WITH ADVANCED SOLID TUMORS (STS): PHASE I STUDY RESULTS
    Heath, E. I.
    Blumenschein, G. R.
    Cohen, R. B.
    LoRusso, P. Mucci
    LoConte, N.
    Kim, S. T.
    Chao, R.
    Wilding, G.
    ANNALS OF ONCOLOGY, 2008, 19 : 156 - 156
  • [49] The impact of drug administration sequence and pharmacokinetic interaction in a phase I study of the combination of docetaxel and gemcitabine in patients with advanced solid tumors
    Dumez, H
    Louwerens, M
    Pawinsky, A
    Planting, AST
    de Jonge, MJA
    Van Oosterom, AT
    Highley, M
    Guetens, G
    Mantel, M
    De Boeck, G
    de Bruijn, E
    Verweij, J
    ANTI-CANCER DRUGS, 2002, 13 (06) : 583 - 593
  • [50] A phase I study of indoximod in combination with docetaxel in metastatic solid tumors
    Jackson, Erica
    Dees, Elizabeth Claire
    Kauh, John S.
    Harvey, R. Donald
    Neuger, Anthony
    Lush, Richard
    Antonia, Scott J.
    Minton, Susan E.
    Ismail-Khan, Roohi
    Han, Hyo S.
    Vahanian, Nicholas N.
    Ramsey, William Jay
    Link, Charles J.
    Streicher, Howard
    Sullivan, Daniel
    Soliman, Hatem Hussein
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
12345